T D Bjornsson - Concepedia

Author

T D Bjornsson

Duke Medical Center

Also Known As

T BJORNSSON, T D Bjornsson, T. D. Bjornsson, T.D. Bjornsson, Therez Bjornsson

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Duke Medical Center Thomas Jefferson University United States Military Academy Jefferson College Duke University Hospital

About

T D Bjornsson is an author at Duke Medical Center specializing in medicine, pharmacology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	530
2	Biochemistry	3	3	138
3	Health Sciences	2	2	186
4	Natural Sciences	2	2	65
5	Biomedical Engineering	1	1	113

T D Bjornsson

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Lidocaine plasma protein binding PA Routledge, Aaron Barchowsky, T D Bjornsson, Clinical Pharmacology & Therapeutics	1980	163
Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. T D Bjornsson, Daniela Schneider, H. Berger Journal of Pharmacology and Experimental Therapeutics	1989	138
Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers. Michael R. Goldberg, Wesley Tanaka, Aaron Barchowsky, Hypertension	1993	133
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. Steven R. Hanson, Laurence A. Harker, T D Bjornsson Journal of Clinical Investigation PharmacotherapyPlatelet Cyclooxygenase InhibitionThrombosisVenous ThrombosisRelative Capacities	1985	123
Acidic fibroblast growth factor promotes vascular repair. T D Bjornsson, Maciej L. Dryjski, J. P. Tluczek, Proceedings of the National Academy of Sciences PathologyIntravascular InjuryBiomedical EngineeringGrowth Factor TreatmentRegenerative Medicine	1991	113
Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174 Jacqueline B. McCrea, Alastair E. Cribb, Tom Rushmore, Clinical Pharmacology & Therapeutics BiochemistryMedicineBioanalysisPhysiologyGenotypic Investigations	1999	73
Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates. Adam Zalewski, Yi Shi, Donald Nardone, Circulation	1991	64
Wheat gluten challenge in schizophrenic patients Steven G. Potkin, D.R. Weinberger, Joel E. Kleinman, American Journal of Psychiatry NutritionFood IntolerancePsychiatryPsychotic DisorderCeliac Disease	1981	57
The artifactual nature of heparin-induced drug protein-binding alterations James E. Brown, Barbara B. Kitchell, T D Bjornsson, Clinical Pharmacology & Therapeutics	1981	52
Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques W. Zhang, Brett Johnson, Dorothy E. Suri, Acta Neuropathologica Alzheimer's DiseaseAutoimmune DiseaseAmyloid PlaquesPathologyAutoimmunity	1998	47

Page 1